What is the equity of Affimed this year?
Affimed has equity of 57.81 M EUR this year.
Affimed Equity 2024
Affimed Equity
57.81 M EUR
Ticker
AFMD
ISIN
NL0010872420
WKN
A12BHU
In 2024, Affimed's equity was 57.81 M EUR, a -62.2% increase from the 152.91 M EUR equity in the previous year.
Affimed Aktienanalyse
What does Affimed do?
Affimed NV is a company specializing in the research, development, and marketing of immunotherapies for various types of cancer. The company was founded in 2000 and is headquartered in Heidelberg, Germany. It has been listed on the NASDAQ since 2014. Affimed focuses on developing innovative immunotherapies that adapt the body's immune defense mechanisms. The goal is to stimulate the body's defense against cancer cells. The company divides its work into three areas, reflected in its product range: 1. NK cell engager platform (NKG2D and CD16A engagers) 2. T cell engager platform (tandem fusions and bi- and tri-specifics) 3. ACCEL platform® (antibody-cell conjugates, enhanced loading) Affimed specializes in developing medicines for specific types of cancer with high medical needs, such as certain forms of lymphomas and solid tumors. The company collaborates with other companies to jointly develop and market medications. Its business model is based on partnerships to finance the development and commercialization of medications. In summary, Affimed NV specializes in the development of targeted immunotherapies for combating cancer cells. Its products specifically target NK cells and T cells and aim to promote an effective immune response against certain types of cancer. The company collaborates with other companies to advance therapy development and bring them to market. Affimed NV specializes in the development of immunotherapies for targeted treatment of cancer cells. Affimed ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Affimed's Equity
Affimed's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Affimed's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Affimed's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Affimed's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Affimed’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Affimed stock
What was the equity of Affimed compared to the previous year?
The equity of Affimed has increased/decreased by -62.2% decreased compared to the previous year.
What impact does a high equity have on investors of Affimed?
A high equity is advantageous for investors of Affimed as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Affimed?
A low equity can be a risk for investors of Affimed, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Affimed affect the company?
An increase in equity of Affimed can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Affimed affect the company?
A reduction in equity of Affimed can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Affimed?
Some factors that can affect the equity of Affimed include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Affimed so important for investors?
The equity of Affimed is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Affimed take to change the equity?
To change equity, Affimed can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Affimed pay?
Over the past 12 months, Affimed paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Affimed is expected to pay a dividend of 0 EUR.
What is the dividend yield of Affimed?
The current dividend yield of Affimed is .
When does Affimed pay dividends?
Affimed pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Affimed?
Affimed paid dividends every year for the past 0 years.
What is the dividend of Affimed?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Affimed located?
Affimed is assigned to the 'Health' sector.
Wann musste ich die Aktien von Affimed kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Affimed from 12/18/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.
When did Affimed pay the last dividend?
The last dividend was paid out on 12/18/2024.
What was the dividend of Affimed in the year 2023?
In the year 2023, Affimed distributed 0 EUR as dividends.
In which currency does Affimed pay out the dividend?
The dividends of Affimed are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Affimed stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Affimed
Our stock analysis for Affimed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Affimed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
